Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioMarin Pharmaceutical Inc. on Target for Its 15% Revenue Growth Goal

TheMotleyFool 
0 0 01.11.17
BioMarin Pharmaceutical Inc. on Target for Its 15% Revenue Growth Goal
 
BioMarin Pharmaceutical Inc. on Target for Its 15% Revenue Growth Goal

It was a solid third quarter for BioMarin Pharmaceutical (NASDAQ: BMRN) as the biotech keeps plugging along, increasing sales of its orphan drugs while making progress on its pipeline drug candidates.

Metric

Q3 2017

Continue reading


Source: Fool.com

BioMarin Pharmaceutical Inc. Stock

€77.90
-0.990%
BioMarin Pharmaceutical Inc. shows a slight decrease today, losing -€0.780 (-0.990%) compared to yesterday.
BioMarin Pharmaceutical Inc. is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
With a target price of 102 € there is a positive potential of 30.94% for BioMarin Pharmaceutical Inc. compared to the current price of 77.9 €.
Show more
Like: 0
BMRN
Share

Comments

Not a member yet? Sign up for free!